3Kralev S,Schneider K,Lang S,et al.Incidence and severity of coronary artery disease in patients with atrial fibrillation undergoing first-time coronary angiography.PLoS One,2011,6:e24964.
4You JJ,Singer DE,Howard PA,et al.Antithrombotic therapy for atrial fibrillation:Antithrombotic Therapy and Prevention of Thrombosis,9th ed:American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Chest,2012,141:e531S-e575S.
5Liu X,Huang H,Yu J,et al.Warfarin compared with aspirin for older Chinese patients with stable coronary heart diseases and atrial fibrillation complication.Int J Clin Pharmacol Ther,2014,6:454-459.
6Wann LS,Curtis AB,January CT,et al.2011ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation(updating the 2006guideline):a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelinces.Circulation,2011,123:104-123.
7January CT,Wann LS,Alpert JS,et al.2014AHA/ACC/HRS guideline for the management of patients with atrial fibrillation:executive summary:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelinces and the Heart Rhythm Society.J Am Coll Cardiol,2014,64:e1-e76.
8Hori M,Connolly SJ,Zhu J,et al.Dabigatran versus warfarin:effects on ischemic and hemorrhagic strokes and bleeding in Asians and non-Asians with atrial fibrillation.Stroke,2013,44:1891-1896.
10Pokorney SD,Simon DN,Thomas L,et al.Patients'time in therapeutic range on warfarin among US patients with atrial fibrillation:Results from ORBIT-AF registry.Am Heart J,2015,170:141-148.
